Literature DB >> 4285635

Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract.

J Simon, V Vonka, Z Janda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 4285635

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  7 in total

1.  NEUROVIRULENCE FOR MONKEYS OF SABIN'S TYPE 1 POLIOVIRUS PASSED THROUGH HUMAN INTESTINES AS COMPARED WITH ATTENUATED AND VIRULENT POLIOVIRUS STRAINS.

Authors:  J SIMON
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1964

2.  THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.

Authors:  V VONKA; Z JANDA; J SIMON
Journal:  Arch Gesamte Virusforsch       Date:  1964-06-17

3.  PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. 3. A SMALL SCALE TRIAL WITH USOL-D BAC VIRUS IN A CLOSED CHILD COMMUNITY.

Authors:  V VONKA; Z JANDA; J SIMON; E ADAM; H ZAVADOVA; M STAREK
Journal:  Arch Gesamte Virusforsch       Date:  1965

4.  PROPERTIES OF A NEW ATTENUATED TYPE 3 POLIOVIRUS. II. NEUROVIRULENCE TESTS ON MONKEYS.

Authors:  J SIMON
Journal:  Arch Gesamte Virusforsch       Date:  1965

5.  Present position of immunization against poliomyelitis with live virus vaccines.

Authors:  A B SABIN
Journal:  Br Med J       Date:  1959-03-14

6.  Properties and behavior of orally administered attenuated poliovirus vaccine.

Authors:  A B SABIN
Journal:  J Am Med Assoc       Date:  1957-07-13

7.  [Active immunization against poliomyelitis with an attenuated virus vaccine. II. First report on the use of the Sabin vaccine in the Netherlands].

Authors:  J D VERLINDE; J B WILTERDINK; B HOFMAN; A KRET
Journal:  Ned Tijdschr Geneeskd       Date:  1958-06-14
  7 in total
  2 in total

1.  Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus.

Authors:  Z Janda; E Adam; V Vonka
Journal:  Arch Gesamte Virusforsch       Date:  1967

2.  USOL-D bac (type 3 poliovirus) vaccine studies.

Authors: 
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.